Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.